These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epigenetics in prostate cancer: biologic and clinical relevance. Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191 [TBL] [Abstract][Full Text] [Related]
4. [Epigenetic mechanism of cardiac differentiation of stem cells]. Zhu H; Liu Y; Zhang Z Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1217-21. PubMed ID: 22246356 [TBL] [Abstract][Full Text] [Related]
5. Epigenetics: a new link between nutrition and cancer. Supic G; Jagodic M; Magic Z Nutr Cancer; 2013; 65(6):781-92. PubMed ID: 23909721 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular epigenetics: from DNA methylation to microRNAs. Udali S; Guarini P; Moruzzi S; Choi SW; Friso S Mol Aspects Med; 2013; 34(4):883-901. PubMed ID: 22981780 [TBL] [Abstract][Full Text] [Related]
7. What can we learn from epigenetics in the year 2009? Jüngel A; Ospelt C; Gay S Curr Opin Rheumatol; 2010 May; 22(3):284-92. PubMed ID: 20305560 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic biomarkers in prostate cancer: Current and future uses. Chiam K; Ricciardelli C; Bianco-Miotto T Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123 [TBL] [Abstract][Full Text] [Related]
9. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Berdasco M; Esteller M Dev Cell; 2010 Nov; 19(5):698-711. PubMed ID: 21074720 [TBL] [Abstract][Full Text] [Related]
10. DNA methylomes, histone codes and miRNAs: tying it all together. Guil S; Esteller M Int J Biochem Cell Biol; 2009 Jan; 41(1):87-95. PubMed ID: 18834952 [TBL] [Abstract][Full Text] [Related]
12. How to analyse epigenetic marks? Ammerpoht O; Siebert R Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():511-4. PubMed ID: 22423507 [TBL] [Abstract][Full Text] [Related]
13. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Herranz M; Esteller M Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic mechanisms in gastric cancer. Gigek CO; Chen ES; Calcagno DQ; Wisnieski F; Burbano RR; Smith MA Epigenomics; 2012 Jun; 4(3):279-94. PubMed ID: 22690664 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic mechanisms and endocannabinoid signalling. D'Addario C; Di Francesco A; Pucci M; Finazzi Agrò A; Maccarrone M FEBS J; 2013 May; 280(9):1905-17. PubMed ID: 23305292 [TBL] [Abstract][Full Text] [Related]
16. Interplay between different epigenetic modifications and mechanisms. Murr R Adv Genet; 2010; 70():101-41. PubMed ID: 20920747 [TBL] [Abstract][Full Text] [Related]
17. Next-generation technologies and data analytical approaches for epigenomics. Mensaert K; Denil S; Trooskens G; Van Criekinge W; Thas O; De Meyer T Environ Mol Mutagen; 2014 Apr; 55(3):155-70. PubMed ID: 24327356 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic biomarkers in colorectal cancer diagnostics. Rawson JB; Bapat B Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic programming of neurodegenerative diseases by an adverse environment. Babenko O; Kovalchuk I; Metz GA Brain Res; 2012 Mar; 1444():96-111. PubMed ID: 22330722 [TBL] [Abstract][Full Text] [Related]